Showing results (321-330 of 398) with videos related to

Sort By:
Pageof 40
Clinical Cardiology|August 1, 2018
TIMI-AF score and cardiovascular events in vitamin K antagonists-naïve outpatients with atrial fibrillationAlejandro Isidoro Pérez Cabeza, Rafael Bravo Marques, Pedro Antonio Chinchurreta Capote, et al.
Journal of Medicinal Chemistry|October 13, 2025
"Precision on Two Wheels"─Structural Refinement of 64Cu- and 68Ga-Labeled Bicyclic Peptides Targeting Nectin-4 for Improved Tumor Imaging: From Preclinical Development to First-in-Human ApplicationTobias Krönke, Johanna Trommer, Martin Ullrich, et al.
JCO Precision Oncology|October 11, 2021
Patients' Expectations of Benefits From Large-Panel Genomic Tumor Testing in Rural Community Oncology PracticesEric C Anderson, John DiPalazzo, Emily Edelman, et al.
BMC Geriatrics|May 20, 2026
CSF neurofilament light chain concentration in patients with delirium following hip fracture: a multicenter prospective studyIrit Titlestad, Leiv Otto Watne, Kaj Blennow, et al.
European Journal of Neurology|December 8, 2023
Pulmonary arteriovenous malformations in patients with previous brain abscess: a cross-sectional population-based studyJacob Bodilsen, Trine Madsen, Christian Thomas Brandt, et al.
Acta Neuropathologica|September 10, 2024
Integrated analyses reveal two molecularly and clinically distinct subtypes of H3 K27M-mutant diffuse midline gliomas with prognostic significanceLotte Stegat, Alicia Eckhardt, Antonia Gocke, et al.
Nature Medicine|April 29, 2025
Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosisLuisa Klotz, Joost Smolders, Jussi Lehto, et al.
The American Journal of Surgical Pathology|March 19, 2021
Atypical Teratoid/Rhabdoid Tumor (AT/RT) With Molecular Features of Pleomorphic XanthoastrocytomaChristian Thomas, Aniello Federico, Martin Sill, et al.
Scientific Reports|April 9, 2022
Pseudoprogression prediction in high grade primary CNS tumors by use of radiomicsAsena Petek Ari, Burak Han Akkurt, Manfred Musigmann, et al.
Heliyon|August 15, 2022
Radiomics for pseudoprogression prediction in high grade gliomas: added value of MR contrast agentOrkhan Mammadov, Burak Han Akkurt, Manfred Musigmann, et al.
Pageof 40